Université de Strasbourg, CNRS, Institut Charles Sadron UPR 22, F-67000 Strasbourg, France; Université de Strasbourg, CNRS, Laboratoire de conception et application de molecules bioactives UMR 7199, F-67000 Strasbourg, France.
Université de Strasbourg, CNRS, Laboratoire de conception et application de molecules bioactives UMR 7199, F-67000 Strasbourg, France.
J Control Release. 2020 May 10;321:285-311. doi: 10.1016/j.jconrel.2020.02.019. Epub 2020 Feb 11.
Hyperbranched polymers (HBPs) have found use in a wide range of applications, such as optical, electronic and magnetic materials, coatings, additives, supramolecular chemistry, and biomedicine. HBPs have gained attention for the development of drug delivery systems due to the presence of internal cavities in their three-dimensional globular structure that can be used to encapsulate drugs and their facile synthesis as compared to dendrimers. The composition, topology, and functionality of HBPs have been tuned to design drug carriers with better efficacies. Recent advances have been reported to introduce functional groups to enhance targeting tumor cells. HBPs have been modified to promote passive and active targeting. This review article will describe the different routes to synthesize hyperbranched polymer, their use as drug carriers for targeted drug delivery, and their functionalization with ligands for active targeting through various synthesis strategies to give the reader an extended overview of the progresses accomplished in this field. The modification of HBPs with ligands such as peptides, oligonucleotides, and folic acid have been demonstrated to enhance the accumulation of the drug selectively at the tumor sites. The potential uses and developments of HBPs as nanoobjects for theranostics for example are discussed as perspectives.
超支化聚合物(HBPs)在光学、电子和磁性材料、涂料、添加剂、超分子化学和生物医药等多个领域都得到了广泛应用。由于其三维球形结构内部存在空腔,可用于封装药物,且与树枝状聚合物相比易于合成,HBPs 成为了药物传递系统开发的热点。通过调整 HBPs 的组成、拓扑结构和功能,可以设计出具有更好疗效的药物载体。最近的研究进展表明,可以引入功能性基团来增强对肿瘤细胞的靶向作用。HBPs 已被修饰以促进被动和主动靶向。本文综述了不同的合成方法来制备超支化聚合物,及其作为靶向药物传递的药物载体,以及通过各种合成策略对其进行配体功能化以实现主动靶向,为读者提供该领域进展的扩展概述。已经证明,用配体如肽、寡核苷酸和叶酸对 HBPs 进行修饰,可以增强药物在肿瘤部位的选择性积累。本文还讨论了 HBPs 作为用于治疗诊断的纳米物体的潜在用途和发展,例如。
J Control Release. 2020-5-10
Chem Soc Rev. 2015-6-21
Adv Mater. 2010-11-2
Acc Chem Res. 2014-4-29
J Colloid Interface Sci. 2017-11-9
J Nanobiotechnology. 2025-2-7
J Mater Chem B. 2025-2-12
Des Monomers Polym. 2024-7-26